Bear Stearns Health Innoventures Management, L.L.C. is a venture capital firm specializing in early and mid stage investments.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Oct 21, 2006
Tolerx
|
Series D | $61M | Biotechnology | Yes |
Jul 18, 2005
Affymax
|
Series D | $60M | Biopharma | Yes |
Mar 29, 2005
Tolerx
|
Series D | $31M | Biotechnology | Yes |
Oct 12, 2004
PharmAthene
|
Series B | $50M | Biotechnology | Yes |
Aug 7, 2004
AGY Therapeutics
|
Series C | $9M | Biopharma | — |
Bear Stearns Health Innoventures L.P has had 6 exits. Bear Stearns Health Innoventures L.P most notable exits include Affymax , Raven Biotechnologies
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Jun 6, 2013 | Affymax | IPO | Biopharma | Detail |
Jul 17, 2008 | Raven Biotechnologies | M&A | Biotechnology | Detail |
Oct 22, 2006 | Corus Pharma | M&A | Biotechnology | Detail |
Apr 1, 2006 | Entelos | IPO | Biotechnology | Detail |
Oct 14, 2005 | PharmAthene | M&A | Biotechnology | Detail |